About Careers Internship MedBlog Contact us

Affordable Vaccine for Rotavirus Diarrhoea Developed

by Sheela Philomena on May 14, 2013 at 10:00 PM
 Affordable Vaccine for Rotavirus Diarrhoea Developed

An affordable vaccine that has shown strong efficacy in preventing rotavirus diarrhoea has been developed by Indian scientists. Rotavirus diarrhoea is the most severe and lethal cause of childhood diarrhoea that kills over 100,000 children annually.

The vaccine 'Rotovac' is the outcome of public-private partnership between the Indian government's Department of Biotechnology (DBT) and pharma company Bharat Biotech.


Once licensed by the Drugs Controller General of India (DCGI), the vaccine will cost around Rs.54 per dose compared to the currently available vaccine which costs Rs.2,250 per dose. Each child needs to take three doses as part of vaccination.

"This is an important scientific breakthrough against rotavirus infections, the most severe and lethal cause of childhood diarrhoea, responsible for approximately 100,000 deaths of small children in India each year and rotavirus vaccine can save 60,000 deaths," said DBT Secretary K. Vijay Raghavan.

"The clinical results indicate that the vaccine, if licensed, could save the lives of thousands of Indian children who get rotavirus diarrhoea every year," he said.

As part of clinical trials, 7,000 infants from low income families in Delhi, Pune and Vellore were administered the vaccine.

"The clinical trials show that the vaccine is efficacious in reducing severe rotavirus diarrhoea by 56 percent during the first year of life, with protection continuing into the second year of life while it reduces the deaths by over 75 percent," said M.K. Bhan, former DBT secretary and currently advisor to the Indian Academy of Paediatrics.

The vaccine originated from an attenuated (weakened) strain of rotavirus that was isolated from an Indian child at the All India Institute of Medical Sciences in New Delhi in 1985-86.

"This is the first time that India has developed a vaccine and it is totally indigenous as strain was taken from an Indian infant, the vaccine was manufactures in India and clinical trials were also done in India," said Bhan.

"With its low price and strong efficacy, the vaccine has the potential to significantly reduce the incidence of severe diarrhoea due to rotavirus among children in India. It can also help in reducing infant deaths in other developing countries," he added.

The oral vaccine can be given alongside routine immunization vaccines like polio vaccine and others.

"It represents the successful research and development of a novel vaccine from the developing world with global standards," said Krishna M. Ella, chairman and managing director of Bharat Biotech.

Source: IANS
Font : A-A+



Recommended Readings

Latest Drug News

Projected Growth: Psychedelic Drug Market Anticipated to Hit $7.2 Billion by 2029
The psychedelic market set for remarkable growth, projected to hit $7.2B by 2029 with a strong 55% CAGR.
Promising ALS Drug Candidate Extends Lifespan
The study explores whether CDNF could influence the progression of ALS in rodent models and to elucidate the mechanism through which it operates.
Amoxicillin-Calvulanate Vs Amoxicillin Preference in Child Sinusitis Treatment
Amoxicillin-clavulanate use in acute sinusitis patients is associated with a higher incidence of adverse events.
ADHD Medication Errors Surge by Nearly 300%
Professionals advocate for enhanced education of patients and caregivers, and creation of more effective child-resistant systems for monitoring ADHD medication.
Unknown Medication Side Effects Reported by 52% of Indian Families
In June, WHO raised concerns about 7 Indian cough syrups after complaints from several countries about contamination and health issues.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

Affordable Vaccine for Rotavirus Diarrhoea Developed Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests